Your browser doesn't support javascript.
loading
Linking a European cohort of children born with congenital anomalies to vital statistics and mortality records: A EUROlinkCAT study.
Loane, M; Given, J E; Tan, J; Reid, A; Akhmedzhanova, D; Astolfi, G; Barisic, I; Bertille, N; Bonet, L B; Carbonell, C C; Carollo, O Mokoroa; Coi, A; Densem, J; Draper, E; Garne, E; Gatt, M; Glinianaia, S V; Heino, A; Hond, E Den; Jordan, S; Khoshnood, B; Kiuru-Kuhlefelt, S; Klungsøyr, K; Lelong, N; Lutke, L R; Neville, A J; Ostapchuk, L; Puccini, A; Rissmann, A; Santoro, M; Scanlon, I; Thys, G; Tucker, D; Urhoj, S K; de Walle, H E K; Wellesley, D; Zurriaga, O; Morris, J K.
Afiliación
  • Loane M; Faculty of Life and Health Sciences, Ulster University, Northern Ireland, United Kingdom.
  • Given JE; Faculty of Life and Health Sciences, Ulster University, Northern Ireland, United Kingdom.
  • Tan J; Population Health Research Institute, St George's, University of London, London, United Kingdom.
  • Reid A; Population Health Research Institute, St George's, University of London, London, United Kingdom.
  • Akhmedzhanova D; OMNI-Net for Children International Charitable Fund, Rivne Regional Medical Diagnostic Center, Rivne, Ukraine.
  • Astolfi G; Emilia Romagna Registry of Birth Defects, University Hospital of Ferrara, Ferrara, Italy.
  • Barisic I; Klinika za djecje bolesti, Zagreb, Croatia.
  • Bertille N; Institut National de la Santé et de la Recherche Médicale, Paris, France.
  • Bonet LB; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.
  • Carbonell CC; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.
  • Carollo OM; Departamento de Salud Gobierno Vasco, Basque Country, Spain.
  • Coi A; Unit of Epidemiology of Rare Diseases and Congenital Anomalies, Institute of Clinical Physiology, National Research Council, Pisa, Italy.
  • Densem J; Biomedical Computing Limited, Battle, United Kingdom.
  • Draper E; East Midlands & South Yorkshire Congenital Anomaly Registry, University of Leicester, Leicester, United Kingdom.
  • Garne E; Hospital Lillebaelt, Region Syddanmark, Denmark.
  • Gatt M; Directorate for Health Information and Research, G'Mangia, Malta.
  • Glinianaia SV; Faculty of Medical Sciences, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Heino A; Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Hond ED; Provinciaal Instituut voor Hygiëne (PIH), Antwerpen, Belgium.
  • Jordan S; Swansea University, Wales, United Kingdom.
  • Khoshnood B; Institut National de la Santé et de la Recherche Médicale, Paris, France.
  • Kiuru-Kuhlefelt S; Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Klungsøyr K; Division of Mental and Physical Health, Department of Global Public Health and Primary Care, Norwegian Institute of Public Health, University of Bergen, Bergen, Norway.
  • Lelong N; Institut National de la Santé et de la Recherche Médicale, Paris, France.
  • Lutke LR; Department of Genetics, University Medical Center, University of Groningen, Groningen, The Netherlands.
  • Neville AJ; Emilia Romagna Registry of Birth Defects, University Hospital of Ferrara, Ferrara, Italy.
  • Ostapchuk L; OMNI-Net for Children International Charitable Fund, Rivne Regional Medical Diagnostic Center, Rivne, Ukraine.
  • Puccini A; Territorial Care Service, Emilia Romagna Health Authority, Bologna, Italy.
  • Rissmann A; Medical Faculty Otto-von-Guericke, Malformation Monitoring Centre Saxony-Anhalt, University Magdeburg, Magdeburg, Germany.
  • Santoro M; Unit of Epidemiology of Rare Diseases and Congenital Anomalies, Institute of Clinical Physiology, National Research Council, Pisa, Italy.
  • Scanlon I; Swansea University, Wales, United Kingdom.
  • Thys G; Provinciaal Instituut voor Hygiëne (PIH), Antwerpen, Belgium.
  • Tucker D; Public Health Wales, Wales, United Kingdom.
  • Urhoj SK; Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.
  • de Walle HEK; Department of Genetics, University Medical Center, University of Groningen, Groningen, The Netherlands.
  • Wellesley D; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom.
  • Zurriaga O; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.
  • Morris JK; Population Health Research Institute, St George's, University of London, London, United Kingdom.
PLoS One ; 16(8): e0256535, 2021.
Article en En | MEDLINE | ID: mdl-34449798
EUROCAT is a European network of population-based congenital anomaly (CA) registries. Twenty-one registries agreed to participate in the EUROlinkCAT study to determine if reliable information on the survival of children born with a major CA between 1995 and 2014 can be obtained through linkage to national vital statistics or mortality records. Live birth children with a CA could be linked using personal identifiers to either their national vital statistics (including birth records, death records, hospital records) or to mortality records only, depending on the data available within each region. In total, 18 of 21 registries with data on 192,862 children born with congenital anomalies participated in the study. One registry was unable to get ethical approval to participate and linkage was not possible for two registries due to local reasons. Eleven registries linked to vital statistics and seven registries linked to mortality records only; one of the latter only had identification numbers for 78% of cases, hence it was excluded from further analysis. For registries linking to vital statistics: six linked over 95% of their cases for all years and five were unable to link at least 85% of all live born CA children in the earlier years of the study. No estimate of linkage success could be calculated for registries linking to mortality records. Irrespective of linkage method, deaths that occurred during the first week of life were over three times less likely to be linked compared to deaths occurring after the first week of life. Linkage to vital statistics can provide accurate estimates of survival of children with CAs in some European countries. Bias arises when linkage is not successful, as early neonatal deaths were less likely to be linked. Linkage to mortality records only cannot be recommended, as linkage quality, and hence bias, cannot be assessed.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anomalías Congénitas / Certificado de Nacimiento / Estadísticas Vitales Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Male / Newborn / Pregnancy País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anomalías Congénitas / Certificado de Nacimiento / Estadísticas Vitales Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Male / Newborn / Pregnancy País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido